Medlive Technology Co., Ltd.

Sümbol: 2192.HK

HKSE

8.51

HKD

Turuhind täna

23.3856
P/E suhe
-0.5721
PEG suhe
6.19B
MRK Cap
0.02%
DIV tootlus

Medlive Technology Co., Ltd. (2192-HK) Finantsaruanded

Q: Mis on Medlive Technology Co., Ltd. (2192.HK) koguvara?

Medlive Technology Co., Ltd. (2192.HK) koguvara on .

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Medlive Technology Co., Ltd. (2192.HK) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Medlive Technology Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln USD Growth	2022	2020	2018
balance-sheet.row.cash-and-short-term-investments	4400.9	4216.9	3908.7	147.1	38.9	16.5
balance-sheet.row.short-term-investments	42.6	29.6	29.6	1.6	2	0
balance-sheet.row.net-receivables	155.9	124.2	95.9	58.2	58.9	0
balance-sheet.row.inventory	0.1	0.2	0.1	0	2	0
balance-sheet.row.other-current-assets	58.3	35.4	33	1.4	1.3	40
balance-sheet.row.total-current-assets	4572.6	4351.7	4013	208.4	101	56.5
balance-sheet.row.property-plant-equipment-net	11.1	14.6	16.9	15.2	9.2	11
balance-sheet.row.goodwill	192.5	111.5	69.7	0	0	0
balance-sheet.row.intangible-assets	66.7	24.3	9.3	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	259.3	135.9	79	0	0	0
balance-sheet.row.long-term-investments	42.4	63.2	-29.3	0	0	0
balance-sheet.row.tax-assets	8.5	8.3	6.3	3.5	3.6	2.4
balance-sheet.row.other-non-current-assets	0	29.6	29.6	0	0	0
balance-sheet.row.total-non-current-assets	321.2	251.5	102.6	18.7	12.8	13.5
balance-sheet.row.other-assets	0	0	0	0	0	0
balance-sheet.row.total-assets	4893.8	4603.2	4115.6	227.1	113.8	69.9
balance-sheet.row.account-payables	14.8	2.7	6.2	6.3	2.6	2.5
balance-sheet.row.short-term-debt	4.5	5.1	4.2	2.6	3	3
balance-sheet.row.tax-payables	25.7	35.2	31.6	13.3	9.8	2.9
balance-sheet.row.long-term-debt-total	3.6	6.1	9	9.5	1.8	4.3
Deferred Revenue Non Current	-7.5	0	0	-2.1	-0.8	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-
balance-sheet.row.other-current-liab	175	124.9	102.8	55.2	39.3	21.9
balance-sheet.row.total-non-current-liabilities	58.8	38.6	30.2	11.6	2.6	4.7
balance-sheet.row.other-liabilities	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	8.2	11.3	13.2	12.1	4.8	7.4
balance-sheet.row.total-liab	248.6	171.3	143.4	75.6	47.6	35
balance-sheet.row.preferred-stock	0	0	39	0	0	0
balance-sheet.row.common-stock	0	0	0	0	0	0
balance-sheet.row.retained-earnings	284.9	175.3	75.6	140.7	55.5	0
balance-sheet.row.accumulated-other-comprehensive-income-loss	4597.3	308.1	-39	0.7	0.7	0
balance-sheet.row.other-total-stockholders-equity	-284.9	3917.6	3873	10.1	10.1	34.9
balance-sheet.row.total-stockholders-equity	4597.4	4401	3948.7	151.4	66.2	35
balance-sheet.row.total-liabilities-and-stockholders-equity	4893.8	4603.2	4115.6	227.1	113.8	69.9
balance-sheet.row.minority-interest	47.8	30.9	23.5	0	0	0
balance-sheet.row.total-equity	4645.2	4431.9	3972.2	151.4	66.2	35
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-
Total Investments	42.4	92.8	0.3	1.6	2	0
balance-sheet.row.total-debt	8.2	11.3	13.2	12.1	4.8	7.4
balance-sheet.row.net-debt	-4350.1	-4176	-3865.9	-135	-34.1	-9.2

Rahavoogude aruanne

Medlive Technology Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	2022	2020	2018
cash-flows.row.net-income	242.3	135	69.9	104.8	37	16
cash-flows.row.depreciation-and-amortization	0	9	6.1	5.3	4.8	4.4
cash-flows.row.deferred-income-tax	0	0	-13.7	0	0	0
cash-flows.row.stock-based-compensation	10.4	17.2	14.3	0	0	0
cash-flows.row.change-in-working-capital	0	-9.6	-27.9	17.8	-14	2.7
cash-flows.row.account-receivables	0	-25.1	-31.7	1.2	-22.5	0
cash-flows.row.inventory	0	-0.1	-0.1	0	0	0
cash-flows.row.account-payables	0	25.1	31.7	0	0	0
cash-flows.row.other-working-capital	0	-9.5	-27.8	16.6	8.5	0
cash-flows.row.other-non-cash-items	-252.7	-74.5	-4.4	-16.9	0.4	-1
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	0	-7.5	-2	-0.6	-2.4	-3.1
cash-flows.row.acquisitions-net	0	-42.6	-53	-0.6	0	0
cash-flows.row.purchases-of-investments	0	-3579.7	-5.3	-132	0	0
cash-flows.row.sales-maturities-of-investments	0	0.7	5.3	132.6	0	0
cash-flows.row.other-investing-activites	0	43.5	4.4	0.6	0	0
cash-flows.row.net-cash-used-for-investing-activites	0	-3585.6	-50.5	0	-2.4	-3.1
cash-flows.row.debt-repayment	0	-5	-6.5	-2.6	-3.1	-2.4
cash-flows.row.common-stock-issued	0	0	4033.1	0	0	0
cash-flows.row.common-stock-repurchased	0	5	0	0	0	0
cash-flows.row.dividends-paid	0	-12.1	-92	0	0	0
cash-flows.row.other-financing-activites	0	-10.2	-142.6	-0.2	-0.3	-3.5
cash-flows.row.net-cash-used-provided-by-financing-activities	0	-22.4	3792.1	-2.8	-3.4	-5.8
cash-flows.row.effect-of-forex-changes-on-cash	0	329.9	-53.9	0	0	0
cash-flows.row.net-change-in-cash	0	-3200.9	3732	108.2	22.4	13.2
cash-flows.row.cash-at-end-of-period	678.2	678.2	3879.1	147.1	38.9	16.5
cash-flows.row.cash-at-beginning-of-period	678.2	3879.1	147.1	38.9	16.5	3.4
cash-flows.row.operating-cash-flow	0	77.2	44.4	111	28.2	22.1
cash-flows.row.capital-expenditure	0	-7.5	-2	-0.6	-2.4	-3.1
cash-flows.row.free-cash-flow	0	69.7	42.5	110.4	25.8	19

Kasumiaruande rida

Medlive Technology Co., Ltd. tulud muutusid võrreldes eelmise perioodiga NaN%. 2192.HK brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln USD Growth	2022	2020	2018
income-statement-row.row.total-revenue	412	314.1	284.4	213.5	121.6	83.5
income-statement-row.row.cost-of-revenue	160.7	101.3	83.7	57.3	44.4	33.6
income-statement-row.row.gross-profit	251.3	212.7	200.7	156.2	77.2	49.9
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-
income-statement-row.row.other-expenses	-8.9	-8	-0.7	15.3	13.4	-0.1
income-statement-row.row.operating-expenses	173.6	143.4	126.9	53.2	39.2	33.2
income-statement-row.row.cost-and-expenses	334.2	244.7	210.7	110.5	83.6	66.8
income-statement-row.row.interest-income	183.9	66.2	7.7	0.4	0.1	0
income-statement-row.row.interest-expense	0.4	0.5	0.5	0.2	0.3	0.4
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	188.1	0.2	-0.4	1.4	-1	-0.7
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-8.9	-8	-0.7	15.3	13.4	-0.1
income-statement-row.row.total-operating-expenses	188.1	0.2	-0.4	1.4	-1	-0.7
income-statement-row.row.interest-expense	0.4	0.5	0.5	0.2	0.3	0.4
income-statement-row.row.depreciation-and-amortization	9.4	9	6.1	5.3	4.8	4.4
income-statement-row.row.ebitda-caps	-	-	-	-	-	-
income-statement-row.row.operating-income	65	134.8	70.3	103.5	38	16.7
income-statement-row.row.income-before-tax	253.1	135	69.9	104.8	37	16
income-statement-row.row.income-tax-expense	1.4	8.6	24.7	19.7	5.7	1.8
income-statement-row.row.net-income	242.3	117.3	40.6	85.2	31.3	14.2